237 related articles for article (PubMed ID: 16266359)
21. Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale.
Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S29-31. PubMed ID: 15563744
[TBL] [Abstract][Full Text] [Related]
22. Topical lidocaine patch therapy for myofascial pain.
Dalpiaz AS; Lordon SP; Lipman AG
J Pain Palliat Care Pharmacother; 2004; 18(3):15-34. PubMed ID: 15364629
[TBL] [Abstract][Full Text] [Related]
23. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain.
Tremont-Lukats IW; Hutson PR; Backonja MM
Clin J Pain; 2006; 22(3):266-71. PubMed ID: 16514327
[TBL] [Abstract][Full Text] [Related]
24. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain.
White WT; Patel N; Drass M; Nalamachu S
Pain Med; 2003 Dec; 4(4):321-30. PubMed ID: 14750908
[TBL] [Abstract][Full Text] [Related]
25. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
Simpson DM; Gazda S; Brown S; Webster LR; Lu SP; Tobias JK; Vanhove GF;
J Pain Symptom Manage; 2010 Jun; 39(6):1053-64. PubMed ID: 20538187
[TBL] [Abstract][Full Text] [Related]
26. Introduction: chronic pain studies of the lidocaine patch 5% using the Neuropathic Pain Scale.
Jensen MP
Curr Med Res Opin; 2004; 20 Suppl 2():S1-4. PubMed ID: 15563740
[TBL] [Abstract][Full Text] [Related]
27. Lidocaine 5% patch: an open-label naturalistic chronic pain treatment trial and prediction of response.
Fishbain DA; Lewis JE; Cole B; Cutler B; Rosomoff HL; Rosomoff RS
Pain Med; 2006; 7(2):135-42. PubMed ID: 16634726
[TBL] [Abstract][Full Text] [Related]
28. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases.
Nayak S; Cunliffe M
Paediatr Anaesth; 2008 Jun; 18(6):554-8. PubMed ID: 18363625
[TBL] [Abstract][Full Text] [Related]
29. NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
Simpson DM; Brown S; Tobias JK; Vanhove GF;
Clin J Pain; 2014 Feb; 30(2):134-42. PubMed ID: 23446088
[TBL] [Abstract][Full Text] [Related]
30. Differential effects on sensory functions and measures of epidermal nerve fiber density after application of a lidocaine patch (5%) on healthy human skin.
Wehrfritz A; Namer B; Ihmsen H; Mueller C; Filitz J; Koppert W; Leffler A
Eur J Pain; 2011 Oct; 15(9):907-12. PubMed ID: 21530339
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study.
Hans G; Sabatowski R; Binder A; Boesl I; Rogers P; Baron R
Curr Med Res Opin; 2009 May; 25(5):1295-305. PubMed ID: 19366301
[TBL] [Abstract][Full Text] [Related]
32. The analgesic effect of a metered-dose 8% lidocaine pump spray in posttraumatic peripheral neuropathy: a pilot study.
Kanai A; Segawa Y; Okamoto T; Koto M; Okamoto H
Anesth Analg; 2009 Mar; 108(3):987-91. PubMed ID: 19224814
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and safety of lidocaine patch 5%.
Galer BS
J Fam Pract; 2002 Oct; 51(10):867-8; author reply 868. PubMed ID: 12401158
[No Abstract] [Full Text] [Related]
34. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy.
Hughes RA; Umapathi T; Gray IA; Gregson NA; Noori M; Pannala AS; Proteggente A; Swan AV
Brain; 2004 Aug; 127(Pt 8):1723-30. PubMed ID: 15201191
[TBL] [Abstract][Full Text] [Related]
35. Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases.
Hans G; Joukes E; Verhulst J; Vercauteren M
Curr Med Res Opin; 2009 Nov; 25(11):2737-43. PubMed ID: 19788351
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life and its predictive role for analgesic effect in patients with painful polyneuropathy.
Otto M; Bach FW; Jensen TS; Sindrup SH
Eur J Pain; 2007 Jul; 11(5):572-8. PubMed ID: 17049890
[TBL] [Abstract][Full Text] [Related]
37. Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.
Webster LR; Peppin JF; Murphy FT; Lu B; Tobias JK; Vanhove GF
Diabetes Res Clin Pract; 2011 Aug; 93(2):187-197. PubMed ID: 21612836
[TBL] [Abstract][Full Text] [Related]
38. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
39. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy.
Estanislao L; Carter K; McArthur J; Olney R; Simpson D;
J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1584-6. PubMed ID: 15577414
[TBL] [Abstract][Full Text] [Related]
40. Needle-free powder lidocaine delivery system provides rapid effective analgesia for venipuncture or cannulation pain in children: randomized, double-blind Comparison of Venipuncture and Venous Cannulation Pain After Fast-Onset Needle-Free Powder Lidocaine or Placebo Treatment trial.
Zempsky WT; Bean-Lijewski J; Kauffman RE; Koh JL; Malviya SV; Rose JB; Richards PT; Gennevois DJ
Pediatrics; 2008 May; 121(5):979-87. PubMed ID: 18450903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
